|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Share compensation | |||||
| Net realized and unrealized loss on investments and derivatives | |||||
| Net realized and unrealized (gain) loss on investment in related party investment funds | |||||
| Change in fair value of liability-classified capital instruments | |||||
| Gain from sale of consolidated subsidiary | |||||
| Amortization of premium and accretion of discount, net | |||||
| Amortization of intangible assets | |||||
| Other items, net | |||||
| Changes in assets and liabilities: | |||||
| Insurance and reinsurance balances receivable, net | |||||
| Deferred acquisition costs, net | |||||
| Unearned premiums ceded | |||||
| Loss and loss adjustment expenses recoverable, net | |||||
| Deferred tax asset/liability | |||||
| Other assets | |||||
| Interest and dividends receivable | |||||
| Loss and loss adjustment expense reserves | |||||
| Unearned premium reserves | |||||
| Deferred gain on retroactive reinsurance | |||||
| Reinsurance balances payable | |||||
| Other liabilities | |||||
| Held for sale asset | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Proceeds from redemptions from related party investment funds | |||||
| Purchases of debt securities, available-for-sale | |||||
| Purchases of debt securities, trading | |||||
| Purchases of short-term investments | |||||
| Purchases of other investments | |||||
| Proceeds from sales and maturities of debt securities, available-for-sale | |||||
| Proceeds from sales and maturities of debt securities, trading and short-term investments | |||||
| Proceeds from sales and maturities of other investments | |||||
| Change in due to/from brokers, net | |||||
| Acquisition of Sirius Group, net (cash and restricted cash acquired of $740.3) | |||||
| Proceeds from sale of consolidated subsidiary, net of cash sold | |||||
| Net cash provided by investing activities | |||||
| Financing activities | |||||
| Proceeds from issuance of SiriusPoint common shares, net of costs | |||||
| Taxes paid on withholding shares | |||||
| Repayment of loans under an agreement to repurchase | |||||
| Cash dividends paid to preference shareholders | |||||
| Payment of redemption of debt | |||||
| Proceeds from issuance of debt, net of costs | |||||
| Settlement of liability-classified capital instruments | |||||
| Net proceeds from exercise of options | |||||
| Net payments on deposit liability contracts | |||||
| Purchases of SiriusPoint common shares under share repurchase program | |||||
| Change in total noncontrolling interests, net | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplementary information | |||||
| Interest paid in cash | |||||
| Income taxes paid in cash | |||||
Loading...
